{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:26:15Z","timestamp":1793838375800,"version":"4.6.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:00:00Z","timestamp":1793836800000},"content-version":"vor","delay-in-days":115,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["31871402"],"award-info":[{"award-number":["31871402"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LMS26H160016"],"award-info":[{"award-number":["LMS26H160016"]}],"id":[{"id":"https:\/\/ror.org\/04aqat463","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LGD22H030004"],"award-info":[{"award-number":["LGD22H030004"]}],"id":[{"id":"https:\/\/ror.org\/04aqat463","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-026-01603-x","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:05:18Z","timestamp":1783947918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DCAF13: a positive regulator of colon cancer cell proliferation via the AMER2\/ Wnt\/\u03b2-catenin pathway"],"prefix":"10.1038","volume":"10","author":[{"given":"Yu-Xin","family":"Hua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Qing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Ping","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Qun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Bing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"1603_CR1","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/nu11010164","volume":"11","author":"K Thanikachalam","year":"2019","unstructured":"Thanikachalam, K. et al. Colorectal cancer and nutrition. Nutrients 11, 164 (2019).","journal-title":"Nutrients"},{"key":"1603_CR2","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker, E. et al. Colorectal cancer. Lancet 394, 1467\u20131480 (2019).","journal-title":"Lancet"},{"key":"1603_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller, L. H. et al. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA 325, 669\u2013685 (2021).","journal-title":"JAMA"},{"key":"1603_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01276-5","volume":"19","author":"X Xu","year":"2020","unstructured":"Xu, X. et al. Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities. Mol. Cancer 19, 165 (2020).","journal-title":"Mol. Cancer"},{"key":"1603_CR5","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.2174\/13816128113199990300","volume":"19","author":"Y Zhao","year":"2013","unstructured":"Zhao, Y. et al. Cullin-RING Ligases as attractive anti-cancer targets. Curr. Pharm. Des. 19, 3215\u20133225 (2013).","journal-title":"Curr. Pharm. Des."},{"key":"1603_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s13046-019-1358-x","volume":"38","author":"H Cui","year":"2019","unstructured":"Cui, H. et al. DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation. J. Exp. Clin. Cancer Res. 38, 350 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1603_CR7","doi-asserted-by":"publisher","first-page":"100644","DOI":"10.1016\/j.mcpro.2023.100644","volume":"22","author":"J Raisch","year":"2023","unstructured":"Raisch, J. et al. Pulse-SILAC and interactomics reveal distinct DDB1-CUL4-associated factors, cellular functions, and protein substrates. Mol. Cell Proteom. 22, 100644 (2023).","journal-title":"Mol. Cell Proteom."},{"key":"1603_CR8","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201898981","volume":"37","author":"YL Zhang","year":"2018","unstructured":"Zhang, Y. L. et al. DCAF13 promotes pluripotency by negatively regulating SUV39H1 stability during early embryonic development. EMBO J. 37, e98981 (2018).","journal-title":"EMBO J."},{"key":"1603_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00018-024-05185-4","volume":"81","author":"P Ren","year":"2024","unstructured":"Ren, P. et al. CRL4(DCAF13) E3 ubiquitin ligase targets MeCP2 for degradation to prevent DNA hypermethylation and ensure normal transcription in growing oocytes. Cell Mol. Life Sci. 81, 165 (2024).","journal-title":"Cell Mol. Life Sci."},{"key":"1603_CR10","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1111\/cas.15300","volume":"113","author":"BQ Shan","year":"2022","unstructured":"Shan, B. Q. et al. DCAF13 promotes breast cancer cell proliferation by ubiquitin inhibiting PERP expression. Cancer Sci. 113, 1587\u20131600 (2022).","journal-title":"Cancer Sci."},{"key":"1603_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.omtn.2017.12.010","volume":"10","author":"Z Chen","year":"2018","unstructured":"Chen, Z. et al. MicroRNA-300 regulates the ubiquitination of PTEN through the CRL4B(DCAF13) E3 ligase in osteosarcoma cells. Mol. Ther. Nucleic Acids 10, 254\u2013268 (2018).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1603_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00018-024-05446-2","volume":"81","author":"ZY Tang","year":"2024","unstructured":"Tang, Z. Y. et al. DCAF13 promotes ovarian cancer progression by activating FRAS1-mediated FAK signaling pathway. Cell Mol. Life Sci. 81, 421 (2024).","journal-title":"Cell Mol. Life Sci."},{"key":"1603_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.ijbiomac.2017.08.047","volume":"106","author":"S Shafique","year":"2018","unstructured":"Shafique, S. et al. Structural basis for cullins and RING component inhibition: Targeting E3 ubiquitin pathway conductors for cancer therapeutics. Int. J. Biol. Macromol. 106, 532\u2013543 (2018).","journal-title":"Int. J. Biol. Macromol."},{"key":"1603_CR14","doi-asserted-by":"publisher","first-page":"105752","DOI":"10.1016\/j.jbc.2024.105752","volume":"300","author":"K Wu","year":"2024","unstructured":"Wu, K. et al. Modulation of cullin-RING E3 ubiquitin ligase-dependent ubiquitination by small molecule compounds. J. Biol. Chem. 300, 105752 (2024).","journal-title":"J. Biol. Chem."},{"key":"1603_CR15","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse, R. et al. Wnt\/beta-catenin signaling, disease, and emerging therapeutic modalities. Cell 169, 985\u2013999 (2017).","journal-title":"Cell"},{"key":"1603_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/ijc.33811","volume":"150","author":"A Neiheisel","year":"2022","unstructured":"Neiheisel, A. et al. Wnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials. Int. J. Cancer 150, 727\u2013740 (2022).","journal-title":"Int. J. Cancer"},{"key":"1603_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1530\/REP-23-0230","volume":"166","author":"Z da Silva","year":"2023","unstructured":"da Silva, Z. et al. DCAF13 and RNF114 participate in the regulation of early porcine embryo development. Reproduction 166, 401\u2013410 (2023).","journal-title":"Reproduction"},{"key":"1603_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42179-w","volume":"9","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. Maternal DCAF13 regulates chromatin tightness to contribute to embryonic development. Sci. Rep. 9, 6278 (2019).","journal-title":"Sci. Rep."},{"key":"1603_CR19","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1080\/15384101.2020.1859196","volume":"19","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation. Cell Cycle 19, 3622\u20133631 (2020).","journal-title":"Cell Cycle"},{"key":"1603_CR20","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.21037\/tcr-23-1923","volume":"12","author":"M Wang","year":"2023","unstructured":"Wang, M. et al. Function and prognosis analysis of nucleolus protein DCAF13 in breast cancer. Transl. Cancer Res. 12, 3744\u20133751 (2023).","journal-title":"Transl. Cancer Res."},{"key":"1603_CR21","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201022RRR","volume":"37","author":"S Wei","year":"2023","unstructured":"Wei, S. et al. A multidimensional pan-cancer analysis of DCAF13 and its protumorigenic effect in lung adenocarcinoma. FASEB J. 37, e22849 (2023).","journal-title":"FASEB J."},{"key":"1603_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-55851-9","volume":"16","author":"JH He","year":"2025","unstructured":"He, J. H. et al. DCAF13-mediated K63-linked ubiquitination of RNA polymerase I promotes uncontrolled proliferation in Breast Cancer. Nat. Commun. 16, 557 (2025).","journal-title":"Nat. Commun."},{"key":"1603_CR23","doi-asserted-by":"publisher","first-page":"101042831770575","DOI":"10.1177\/1010428317705753","volume":"39","author":"J Cao","year":"2017","unstructured":"Cao, J. et al. The overexpression and prognostic role of DCAF13 in hepatocellular carcinoma. Tumour Biol. 39, 1010428317705753 (2017).","journal-title":"Tumour Biol."},{"key":"1603_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.addr.2020.12.010","volume":"169","author":"M Caspi","year":"2021","unstructured":"Caspi, M. et al. Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders. Adv. Drug Deliv. Rev. 169, 118\u2013136 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1603_CR25","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1634\/theoncologist.2015-0057","volume":"20","author":"D Tai","year":"2015","unstructured":"Tai, D. et al. Targeting the WNT signaling pathway in cancer therapeutics. Oncologist 20, 1189\u20131198 (2015).","journal-title":"Oncologist"},{"key":"1603_CR26","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1080\/10409238.2017.1350135","volume":"52","author":"V Bryja","year":"2017","unstructured":"Bryja, V. et al. The connections of Wnt pathway components with cell cycle and centrosome: side effects or a hidden logic? Crit. Rev. Biochem. Mol. Biol. 52, 614\u2013637 (2017).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"1603_CR27","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.3390\/cells9092125","volume":"9","author":"J Bian","year":"2020","unstructured":"Bian, J. et al. Transcriptional regulation of Wnt\/beta-catenin pathway in colorectal cancer. Cells 9, 2125 (2020).","journal-title":"Cells"},{"key":"1603_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.biochi.2022.01.009","volume":"195","author":"C Disoma","year":"2022","unstructured":"Disoma, C. et al. Wnt\/beta-catenin signaling in colorectal cancer: Is therapeutic targeting even possible? Biochimie 195, 39\u201353 (2022).","journal-title":"Biochimie"},{"key":"1603_CR29","doi-asserted-by":"publisher","first-page":"194933","DOI":"10.1016\/j.bbagrm.2023.194933","volume":"1866","author":"S Tabassum","year":"2023","unstructured":"Tabassum, S. et al. The DEAD-box RNA helicase DDX5 (p68) and \u03b2-catenin: The crucial regulators of FOXM1 gene expression in arbitrating colorectal cancer. Biochim. Biophys. Acta Gene Regul. Mech. 1866, 194933 (2023).","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"1603_CR30","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/s41388-026-03695-y","volume":"45","author":"M Acevedo","year":"2026","unstructured":"Acevedo, M. et al. The deubiquitinase USP17 regulates the expression and activity of the oncogenic driver beta-catenin in colorectal cancer. Oncogene 45, 989\u2013998 (2026).","journal-title":"Oncogene"},{"key":"1603_CR31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2419691122","volume":"122","author":"A Jauregi-Miguel","year":"2025","unstructured":"Jauregi-Miguel, A. et al. The developmental factor TBX3 engages with the Wnt\/beta-catenin transcriptional complex in colorectal cancer to regulate metastasis genes. Proc. Natl. Acad. Sci. USA. 122, e2419691122 (2025).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"1603_CR32","doi-asserted-by":"publisher","first-page":"102703","DOI":"10.1016\/j.tranon.2026.102703","volume":"66","author":"J Zhang","year":"2026","unstructured":"Zhang, J. et al. The VAX2-SERPINE1 axis modulates colorectal cancer cell proliferation and apoptosis through WNT\/beta-catenin signaling. Transl. Oncol. 66, 102703 (2026).","journal-title":"Transl. Oncol."},{"key":"1603_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63685-8","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Cytoplasmic TRIM24 promotes colorectal cancer cell proliferation by activating Wnt\/beta-catenin signaling. Nat. Commun. 16, 8598 (2025).","journal-title":"Nat. Commun."},{"key":"1603_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13046-023-02936-2","volume":"43","author":"S Wei","year":"2024","unstructured":"Wei, S. et al. DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma. J. Exp. Clin. Cancer Res. 43, 3 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1603_CR35","first-page":"181","volume":"18","author":"WJ Zhang","year":"2024","unstructured":"Zhang, W. J. et al. STAT5B suppresses ferroptosis by promoting DCAF13 transcription to regulate p53\/xCT pathway to promote mantle cell lymphoma progression. Biologics 18, 181\u2013193 (2024).","journal-title":"Biologics"},{"key":"1603_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39374-9","volume":"14","author":"Y Sun","year":"2023","unstructured":"Sun, Y. et al. Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex. Nat. Commun. 14, 3762 (2023).","journal-title":"Nat. Commun."},{"key":"1603_CR37","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1126\/science\/1141515","volume":"316","author":"MB Major","year":"2007","unstructured":"Major, M. B. et al. Wilms tumor suppressor WTX negatively regulates WNT\/-catenin signaling. Science 316, 1043\u20131046 (2007).","journal-title":"Science"},{"key":"1603_CR38","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1074\/jbc.M111.308650","volume":"287","author":"AS Pfister","year":"2012","unstructured":"Pfister, A. S. et al. Amer2 protein is a novel negative regulator of Wnt\/beta-catenin signaling involved in neuroectodermal patterning. J. Biol. Chem. 287, 1734\u20131741 (2012).","journal-title":"J. Biol. Chem."},{"key":"1603_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrd4233","volume":"7","author":"M Kahn","year":"2014","unstructured":"Kahn, M. Can we safely target the WNT pathway? Nat. Rev. Drug Discov. 7, 513\u2013532 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1603_CR40","first-page":"195","volume":"2","author":"K Wu","year":"2021","unstructured":"Wu, K. et al. Targeting cullin-RING E3 ubiquitin ligase 4 by small molecule modulators. J. Cell. Signal. 2, 195\u2013205 (2021).","journal-title":"J. Cell. Signal."},{"key":"1603_CR41","doi-asserted-by":"publisher","first-page":"29680","DOI":"10.1074\/jbc.M113.495069","volume":"288","author":"WW Pan","year":"2013","unstructured":"Pan, W. W. et al. Ubiquitin E3 ligase CRL4(CDT2\/DCAF2) as a potential chemotherapeutic target for ovarian surface epithelial cancer. J. Biol. Chem. 288, 29680\u201329691 (2013).","journal-title":"J. Biol. Chem."},{"key":"1603_CR42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2007328118","volume":"118","author":"K Wu","year":"2021","unstructured":"Wu, K. et al. Inhibitors of cullin-RING E3 ubiquitin ligase 4 with antitumor potential. Proc. Natl. Acad. Sci. USA. 118, e2007328118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"1603_CR43","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1016\/j.bmc.2019.02.048","volume":"27","author":"M Girardini","year":"2019","unstructured":"Girardini, M. et al. Cereblon versus VHL: hijacking E3 ligases against each other using PROTACs. Bioorg. Med. Chem. 27, 2466\u20132479 (2019).","journal-title":"Bioorg. Med. Chem."},{"key":"1603_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108846","volume":"164","author":"Y He","year":"2025","unstructured":"He, Y. et al. Application of proteolysis targeting chimeric (PROTAC) technology in protein regulation and drug development. Bioorg. Chem. 164, 108846 (2025).","journal-title":"Bioorg. Chem."},{"key":"1603_CR45","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1016\/j.str.2025.09.006","volume":"33","author":"EJ McMahon","year":"2025","unstructured":"McMahon, E. J. et al. Structural basis for DCAF2 as a novel E3 ligase for PROTAC-mediated targeted protein degradation. Structure 33, 2020\u20132028.e7 (2025).","journal-title":"Structure"},{"key":"1603_CR46","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1039\/D4MD00681J","volume":"16","author":"IA Riha","year":"2024","unstructured":"Riha, I. A. et al. Exploiting the DCAF16-SPIN4 interaction to identify DCAF16 ligands for PROTAC development. RSC Med. Chem. 16, 892\u2013906 (2024).","journal-title":"RSC Med. Chem."},{"key":"1603_CR47","doi-asserted-by":"publisher","first-page":"156001","DOI":"10.1016\/j.prp.2025.156001","volume":"270","author":"MS Hussain","year":"2025","unstructured":"Hussain, M. S. et al. Exploiting E3 ligases for lung cancer therapy: the promise of DCAF-PROTACs. Pathol. Res Pract. 270, 156001 (2025).","journal-title":"Pathol. Res Pract."},{"key":"1603_CR48","doi-asserted-by":"publisher","first-page":"113749","DOI":"10.1016\/j.ejmech.2021.113749","volume":"225","author":"C Wang","year":"2021","unstructured":"Wang, C. et al. Developments of CRBN-based PROTACs as potential therapeutic agents. Eur. J. Med. Chem. 225, 113749 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"1603_CR49","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1021\/acschembio.4c00799","volume":"20","author":"MA Campos","year":"2025","unstructured":"Campos, M. A. et al. Discovery of DCAF16 binders for targeted protein degradation[J]. ACS Chem. Biol. 20, 479\u2013488 (2025).","journal-title":"ACS Chem. Biol."},{"key":"1603_CR50","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41589-019-0279-5","volume":"15","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16. Nat. Chem. Biol. 15, 737\u2013746 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"1603_CR51","doi-asserted-by":"publisher","first-page":"106637","DOI":"10.1016\/j.bioorg.2023.106637","volume":"138","author":"C Pu","year":"2023","unstructured":"Pu, C. et al. Development of PROTAC degrader probe of CDK4\/6 based on DCAF16. Bioorg. Chem. 138, 106637 (2023).","journal-title":"Bioorg. Chem."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01603-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01603-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01603-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:47:08Z","timestamp":1793836028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01603-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1603"],"URL":"https:\/\/doi.org\/10.1038\/s41698-026-01603-x","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"425"}}